NCT02191280View on ClinicalTrials.gov

Antistax® in Patients With Chronic Venous Insufficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

September 30, 1998

Conditions
Venous Insufficiency
Interventions
DRUG

Antistax®, low dose

DRUG

Antistax®, high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY